FundedAndHiringPulse / compare

Septal Solutions, Inc. vs BioLattice Ophthalmics, Inc,: FundedAndHiringPulse comparison

Septal Solutions, Inc.'s offering of 10,000,000 is 3.0x BioLattice Ophthalmics, Inc,'s 3,310,000 (68th percentile). Septal Solutions, Inc. is dated 2026-10-27; BioLattice Ophthalmics, Inc, 2026-10-28.

Data as of · Compiled by Zalwin from SEC EDGAR Form D via FormDPulse (operating companies only, no individuals)

Both records plus every comparable PA record, with all columns and source links · Card, Apple Pay, Google Pay or Link via Stripe

How does Septal Solutions, Inc. compare to BioLattice Ophthalmics, Inc,?

FieldSeptal Solutions, Inc.BioLattice Ophthalmics, Inc,
CompanySeptal Solutions, Inc.BioLattice Ophthalmics, Inc,
LocationExton, PAPhiladelphia, PA
IndustryOther Health CareBiotechnology
Likely hiringHealthcare and life sciences (clinical, R&D)Healthcare and life sciences (clinical, R&D)
Offering$10,000,000$3,310,000
Sold so far$7,319,695$1,825,000
Filed2026-10-27 (9 days ago)2026-10-28 (8 days ago)
Revenue rangeDecline to DiscloseDecline to Disclose
Next stepsFind the company website, then run /jobpostingschemapulse on its careers page or /prospectteardown on its home page.Find the company website, then run /jobpostingschemapulse on its careers page or /prospectteardown on its home page.
Incorporated2023
amount percentile68th34th
Scaling Signal Score85/10085/100
Peer rank and all 5 PA records (CSV) 🔒 Click to unlock →
Official source URLs for every peer record 🔒 Click to unlock →

Official records: Septal Solutions, Inc. · BioLattice Ophthalmics, Inc,

Get new funded companies in your niche every week

FundedAndHiringPulse can email you new filers matching your states, hiring classes and raise sizes.

See plans

Built from SEC Form D filings, which report an offering, not a hiring plan; "likely to hire" is our classification from industry and raise size, not a statement by the company. Filings can be amended or withdrawn; confirm on SEC EDGAR. Companies only; individuals named in filings are not included. Not a consumer report and may not be used for FCRA purposes. Not investment advice.

Often used together